Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
27.27
+1.00 (3.81%)
Dec 31, 2025, 4:00 PM EST - Market closed
Forte Biosciences Market Cap
Forte Biosciences has a market cap or net worth of $486.26 million as of December 31, 2025. Its market cap has increased by 228.54% in one year.
Market Cap
486.26M
Enterprise Value
392.85M
1-Year Change
228.54%
Ranking
Category
Stock Price
$27.27
Market Cap Chart
Since June 16, 2020, Forte Biosciences's market cap has increased from $181.43M to $486.26M, an increase of 168.01%. That is a compound annual growth rate of 19.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 486.26M | 234.91% |
| Dec 31, 2024 | 145.19M | 386.30% |
| Dec 29, 2023 | 29.86M | 42.17% |
| Dec 30, 2022 | 21.00M | -33.49% |
| Dec 31, 2021 | 31.57M | -93.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.25B |
| Johnson & Johnson | 498.60B |
| AbbVie | 403.83B |
| UnitedHealth Group | 299.03B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.26B |
| Novo Nordisk | 227.63B |